(Q48491352)

12 February 2018

title

Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL). (English)

1 reference

12 February 2018

0 references

1 reference

Brada M

1

1 reference

12 February 2018

Hjiyiannakis D

2

1 reference

12 February 2018

Hines F

3

1 reference

12 February 2018

Traish D

4

1 reference

12 February 2018

Ashley S

5

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 March 1998

1 reference

12 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

12 February 2018

volume

40

1 reference

12 February 2018

issue

5

1 reference

12 February 2018

page(s)

1157-1162

1 reference

12 February 2018

Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy alone

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

Central nervous system lymphomas: progress in chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

Increasing incidence of primary brain lymphoma in the US

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

Combined modality therapy for primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900002-9

7 January 2021

10.1016/S0360-3016(98)00002-9

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

9539572

1 reference

12 February 2018